EMERYVILLE, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: MGX), a precision genetic medicines company committed to ...

Previously at Aimmune Therapeutics, Inc., Mr. Ryali held roles of increasing responsibility, most recently as vice president of finance. Earlier in his career, he worked at Onyx Pharmaceuticals ...

Stallergenes Greer, a biopharmaceutical company specialising in allergen immunotherapy (AIT), announces that the European Commission (EC) has approved the extension of indication of Palforzia® ...

Previously at Aimmune Therapeutics, Inc., Mr. Ryali held roles of increasing responsibility, most recently as vice president of finance. Earlier in his career, he worked at Onyx Pharmaceuticals, Inc.

On Monday, Sangamo Therapeutics, Inc. (NASDAQ:SGMO) regained the development and commercialization rights to giroctocogene fitelparvovec, an investigational gene therapy product candidate for ...

Dyne Therapeutics Inc. 2.97% $1.44B ...

Biotech company Aimmune has announced plans to file its potential peanut allergy treatment at the end of the year following its major phase 3 trial success. Aimmune saw its shares surge last month ...

Please provide your email address to receive an email when new articles are posted on . The ACG developed 19 recommendations related to the diagnosis and management of eosinophilic esophagitis ...

Therapeutics are treatments used to alleviate or prevent a particular disease. Examples of therapeutics include drug therapy, medical devices, nutrition therapy and stem-cell therapies ...

New CEO in at Amarna. Dutch gene therapy-focused biotech Amarna Therapeutics also announced a new CEO, Dr Henk Streefkerk, who has served as the company’s medical director for the last year.

Deal Dispatch: Party City Wraps Up, Big Lots Goes Bust, The Container Store Continues Unlike Party City and Big Lots, The Container Store is staying in business. Plus, an oncology company searches ...